Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/11432
Title: | Contributions of meta-analyses based on individual patient data to therapeutic progress in colorectal cancer | Authors: | BUYSE, Marc | Issue Date: | 2009 | Publisher: | SPRINGER TOKYO | Source: | INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 14 (2). p. 95-101 | Abstract: | Meta-analysis is the statistical process of combining information from several studies addressing the same question. Meta-analyses based on individual patient data are far more reliable and informative than those based on summary statistics obtained from the trialists or extracted from the published literature. Meta-analysis of randomized clinical trials may contribute to therapeutic progress through (1) establishing efficacy benefits beyond a reasonable doubt, (2) identifying sources of heterogeneity between trials, (3) studying subsets reliably, (4) confirming differences in toxicity profiles, (5) evaluating the cost-effectiveness of experimental therapies, (6) assessing surrogate endpoints, and (7) addressing ancillary questions. All of these potential contributions are illustrated with examples in early and advanced colorectal cancer. | Notes: | [Buyse, Marc] Int Inst Drug Dev, Louvain, Belgium. [Buyse, Marc] Hasselt Univ, Ctr Stat, Diepenbeek, Belgium. marc.buyse@iddi.com | Keywords: | Meta-analysis; Colorectal cancer;Meta-analysis; Colorectal cancer | Document URI: | http://hdl.handle.net/1942/11432 | ISSN: | 1341-9625 | e-ISSN: | 1437-7772 | DOI: | 10.1007/s10147-009-0879-2 | ISI #: | 000265498500004 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2010 |
Appears in Collections: | Research publications |
Show full item record
SCOPUSTM
Citations
7
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
8
checked on Oct 6, 2024
Page view(s)
144
checked on May 23, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.